• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Systemic mastocytosis with an associated hematological neoplasms: One or two entities?

作者信息

Njue Linet, Porret Naomi, Fux Michaela, Bacher Ulrike, Banz Yara, Rovó Alicia

机构信息

Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital University of Bern Bern Switzerland.

University Institute of Clinical Chemistry, Inselspital, Bern University Hospital University of Bern Bern Switzerland.

出版信息

EJHaem. 2020 Jun 4;1(1):353-355. doi: 10.1002/jha2.22. eCollection 2020 Jul.

DOI:10.1002/jha2.22
PMID:35847724
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9175919/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31c/9175919/82588462c528/JHA2-1-353-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31c/9175919/82588462c528/JHA2-1-353-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31c/9175919/82588462c528/JHA2-1-353-g001.jpg

相似文献

1
Systemic mastocytosis with an associated hematological neoplasms: One or two entities?伴有相关血液系统肿瘤的系统性肥大细胞增多症：一种还是两种疾病实体？
EJHaem. 2020 Jun 4;1(1):353-355. doi: 10.1002/jha2.22. eCollection 2020 Jul.
2
Osteoblastic lesions in systemic mastocytosis associated with hematological malignancy.
Med Clin (Barc). 2021 May 7;156(9):469-470. doi: 10.1016/j.medcli.2020.01.042. Epub 2020 May 24.
3
[Mastocytosis and eosinophilic leukemia: diagnostics and classification].[肥大细胞增多症与嗜酸性粒细胞白血病：诊断与分类]
Pathologe. 2012 Nov;33(6):539-52. doi: 10.1007/s00292-012-1654-0.
4
Systemic mastocytosis with plasma cell dyscrasia: report of a case.系统性肥大细胞增多症伴浆细胞发育异常：一例报告
Leuk Res. 2008 Jul;32(7):1160-3. doi: 10.1016/j.leukres.2007.10.017. Epub 2007 Dec 3.
5
FDA Approval Summary: Midostaurin for the Treatment of Advanced Systemic Mastocytosis.美国食品和药物管理局批准概要：米哚妥林治疗晚期系统性肥大细胞增多症。
Oncologist. 2018 Dec;23(12):1511-1519. doi: 10.1634/theoncologist.2018-0222. Epub 2018 Aug 16.
6
Hodgkin's lymphoma is a rare form of clonal haematological non-mast cell disease in systemic mastocytosis.霍奇金淋巴瘤是系统性肥大细胞增多症中一种罕见的克隆性血液非肥大细胞疾病。
Diagn Pathol. 2015 Mar 14;10:5. doi: 10.1186/s13000-015-0235-y.
7
Systemic mastocytosis in association with chronic lymphocytic leukemia: a rare diagnosis.
Leuk Res. 2007 Dec;31(12):1755-8. doi: 10.1016/j.leukres.2007.04.002. Epub 2007 May 22.
8
Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice.高级系统性肥大细胞增多症：从分子和遗传学进展到临床实践。
Haematologica. 2016 Oct;101(10):1133-1143. doi: 10.3324/haematol.2016.146563.
9
Systemic Mastocytosis in Association with Small Lymphocytic Lymphoma.系统性肥大细胞增多症伴小淋巴细胞淋巴瘤
Am J Case Rep. 2017 Oct 3;18:1053-1057. doi: 10.12659/ajcr.905759.
10
Systemic mastocytosis with associated myeloproliferative neoplasm with t(8;19)(p12;q13.1) and abnormality of FGFR1: report of a unique case.伴有t(8;19)(p12;q13.1)及成纤维细胞生长因子受体1（FGFR1）异常的系统性肥大细胞增多症合并相关骨髓增殖性肿瘤：1例独特病例报告
Int J Clin Exp Pathol. 2014 Jan 15;7(2):801-7. eCollection 2014.

本文引用的文献

1
New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis.晚期系统性肥大细胞增多症的诊断、预后和治疗的新进展。
Blood. 2020 Apr 16;135(16):1365-1376. doi: 10.1182/blood.2019000932.
2
Detection of the KIT mutation in myelodysplastic and/or myeloproliferative neoplasms and acute myeloid leukemia with myelodysplasia-related changes predicts concurrent systemic mastocytosis.检测骨髓增生性和/或骨髓增生异常性肿瘤以及伴有骨髓发育不良相关改变的急性髓系白血病中的 KIT 突变可预测同时存在系统性肥大细胞增多症。
Mod Pathol. 2020 Jun;33(6):1135-1145. doi: 10.1038/s41379-019-0447-x. Epub 2020 Jan 2.
3
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions.
经典慢性髓单核细胞白血病（CMML）、CMML 变异型和 CMML 前期疾病的拟议诊断标准。
Haematologica. 2019 Oct;104(10):1935-1949. doi: 10.3324/haematol.2019.222059. Epub 2019 May 2.
4
Targeted Treatment Options in Mastocytosis.肥大细胞增多症的靶向治疗选择
Front Med (Lausanne). 2017 Jul 20;4:110. doi: 10.3389/fmed.2017.00110. eCollection 2017.
5
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.2016 年版世界卫生组织髓系肿瘤和急性白血病分类。
Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.
6
Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications.系统性肥大细胞增多症外周血中KIT D816V突变的检测：诊断意义
Mod Pathol. 2015 Aug;28(8):1138-49. doi: 10.1038/modpathol.2015.72. Epub 2015 Jun 12.
7
Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD).与系统性肥大细胞增多症（SM-AHNMD）相关的克隆性血液非肥大细胞谱系疾病中 KITD816V 的可变存在。
J Pathol. 2010 Apr;220(5):586-95. doi: 10.1002/path.2677.
8
Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients.成人惰性系统性肥大细胞增多症的预后：西班牙肥大细胞增多症网络对145例患者的长期研究
J Allergy Clin Immunol. 2009 Sep;124(3):514-21. doi: 10.1016/j.jaci.2009.05.003. Epub 2009 Jul 9.
9
KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients.系统性肥大细胞增多症中肥大细胞及其他骨髓造血细胞系的KIT突变：西班牙肥大细胞增多症网络（REMA）对113例患者的前瞻性研究
Blood. 2006 Oct 1;108(7):2366-72. doi: 10.1182/blood-2006-04-015545. Epub 2006 Jun 1.
10
Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia.在一例与慢性粒单核细胞白血病相关的系统性肥大细胞增多症中，对显微切割的骨髓浸润灶中c-kit基因Asp 816至Val突变的检测。
Mol Pathol. 2000 Aug;53(4):188-93. doi: 10.1136/mp.53.4.188.